中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2009年
10期
1035-1037
,共3页
牛磺酸%脑梗死%动脉粥样硬化%高同型半胱氨酸血症
牛磺痠%腦梗死%動脈粥樣硬化%高同型半胱氨痠血癥
우광산%뇌경사%동맥죽양경화%고동형반광안산혈증
Taurine%Cerebral infarction%Atherosclerosis%Homocysteinemia
目的 探讨牛磺酸对高同型半胱氨酸脑梗死患者动脉粥样硬化的治疗作用. 方法选择自2006年9月至2006年12月哈尔滨医科大学附属第一医院神经内科住院的40例高同型半胱氨酸脑梗死患者,按随机数字表法分为牛磺酸治疗组和叶酸、维生素治疗组,相应的药物治疗6个月.治疗前后分别检查颈动脉彩超,观察颈动脉内膜中层厚度(IMT)和斑块变化情况,采血分离血清,采用高压液相色谱分析仪及相应试剂盒测定血浆同型半胱氨酸水平. 结果经治疗6个月后,叶酸、维生素组颈动脉IMT平均厚度减小0.372 mm,牛磺酸治疗组减小0.551 mm,两组在治疗前后颈动脉IMT比较差异均有统计学意义(P<0.05),且牛磺酸治疗组对颈动脉IMT的控制要优于叶酸、维生素治疗组,差异有统计学意义(P<0.05).牛磺酸治疗组治疗前后血浆同型半胱氨酸水平[(29.832±7.750)μmol/Lvs(19.316±2.240)μmol/L]比较差异有统计学意义(P<0.05). 结论牛磺酸对高同型半胱氨酸脑梗死患者动脉粥样硬化的治疗有效且优于叶酸、维生素,并对血浆同型半胱氨酸水平有控制作用.
目的 探討牛磺痠對高同型半胱氨痠腦梗死患者動脈粥樣硬化的治療作用. 方法選擇自2006年9月至2006年12月哈爾濱醫科大學附屬第一醫院神經內科住院的40例高同型半胱氨痠腦梗死患者,按隨機數字錶法分為牛磺痠治療組和葉痠、維生素治療組,相應的藥物治療6箇月.治療前後分彆檢查頸動脈綵超,觀察頸動脈內膜中層厚度(IMT)和斑塊變化情況,採血分離血清,採用高壓液相色譜分析儀及相應試劑盒測定血漿同型半胱氨痠水平. 結果經治療6箇月後,葉痠、維生素組頸動脈IMT平均厚度減小0.372 mm,牛磺痠治療組減小0.551 mm,兩組在治療前後頸動脈IMT比較差異均有統計學意義(P<0.05),且牛磺痠治療組對頸動脈IMT的控製要優于葉痠、維生素治療組,差異有統計學意義(P<0.05).牛磺痠治療組治療前後血漿同型半胱氨痠水平[(29.832±7.750)μmol/Lvs(19.316±2.240)μmol/L]比較差異有統計學意義(P<0.05). 結論牛磺痠對高同型半胱氨痠腦梗死患者動脈粥樣硬化的治療有效且優于葉痠、維生素,併對血漿同型半胱氨痠水平有控製作用.
목적 탐토우광산대고동형반광안산뇌경사환자동맥죽양경화적치료작용. 방법선택자2006년9월지2006년12월합이빈의과대학부속제일의원신경내과주원적40례고동형반광안산뇌경사환자,안수궤수자표법분위우광산치료조화협산、유생소치료조,상응적약물치료6개월.치료전후분별검사경동맥채초,관찰경동맥내막중층후도(IMT)화반괴변화정황,채혈분리혈청,채용고압액상색보분석의급상응시제합측정혈장동형반광안산수평. 결과경치료6개월후,협산、유생소조경동맥IMT평균후도감소0.372 mm,우광산치료조감소0.551 mm,량조재치료전후경동맥IMT비교차이균유통계학의의(P<0.05),차우광산치료조대경동맥IMT적공제요우우협산、유생소치료조,차이유통계학의의(P<0.05).우광산치료조치료전후혈장동형반광안산수평[(29.832±7.750)μmol/Lvs(19.316±2.240)μmol/L]비교차이유통계학의의(P<0.05). 결론우광산대고동형반광안산뇌경사환자동맥죽양경화적치료유효차우우협산、유생소,병대혈장동형반광안산수평유공제작용.
Objective To investigate the therapeutic effect of taurine on atherosclerosis in patients with hyperhomocysteinemia (Hhcy)-induced cerebral infarction (CI). Methods Forty patients with CI induced by Hhcy were randomizod into two equal groups to receive taurine injections or folacin plus vitamin B12 treatment for 6 months. Color Doppler ultrasound was performed to examine the intima-media thickness (IMT) and the plaques in the carotid artery before and after the treatment. Blood samples were obtained from the patients to determine the changes in plasma homocysteic acid (Hcy) level using high-pressure liquid chromatography. Results Both taurine injections and folacin plus vitamin BI2 treatment for 6 months resulted in a significant reduction in the IMT of the carotid artery (P<0.05), but taurine caused a significantly greater reduction (0.551 mm vs 0.372 mm, P<0.05). Taurine also showed a better effect than folacin plus vitamin B12 in decreasing the number of atherosclcrotic plaques (P<0.05). Taurine treatment significantly decreased the plasma Hcy level as compared with the level before treatment (19.316±2.240 μmol/L v, 29.832±7.750 μmol/L, P<0.05). Conclusions Taurine has better therapeutic effect than folacin plus vitamine B12 oil atherosclerosis and helps control plasma Hcy level in patients with Hhcy-induced CI.